IDYA
IDYA
NASDAQ · Biotechnology

Ideaya Biosciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$32.75
+0.15 (+0.46%)
As of Mar 22, 9:59 PM ET ·
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Buy 22 88%
Hold 3 12%
Sell 0 0%
Price Target
Analyst Price Target +259.3% upside
Low Target $81.99
Average Target $117.67
High Target $158.58
Current Price $32.75
Current
$32.75
Target
$117.67
$81.99 $117.67 avg $158.58
Scenario Analysis
Bear Case
$81.99
150.4%
Low target
Base Case
$117.67
+259.3%
Avg target
Bull Case
$158.58
+384.2%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$39.28
-16.6% from high
52-Week Low
$13.45
+143.5% from low
50-Day SMA
$34.24
-4.4% vs SMA
200-Day SMA
$27.52
+19.0% vs SMA
RSI (14)
49.6
Neutral
Target vs 52W High
$117.67
+199.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%